Differential multiple sclerosis treatment allocation between Australia and New Zealand associated with clinical outcomes but not mood or quality of life-Reference-Cited by-同舟云学术

Differential multiple sclerosis treatment allocation between Australia and New Zealand associated with clinical outcomes but not mood or quality of life

Published:2019-05 Issue: Volume:30 Page:25-32
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Phyo Aung Zaw Zaw,Jelinek George A.^ORCID,Brown Chelsea R.,O'Kearney Emily,Neate Sandra L.,De Livera Alysha M,Taylor Keryn L.,Bevens William,Simpson, Steve,Weiland Tracey J.

Funder

Bloom Foundation

Wal Pisciotta

Horne Family Charitable Trust

The Royal Australian and New Zealand College of Psychiatrists

New Investigator Grant

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference33 articles.

1. Quality of life in multiple sclerosis: The impact of depression, fatigue and disability;Amato;Mult. Scler. (Houndmills, Basingstoke, England),2001

2. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurologists;Broadley;J. Clin. Neurosci.,2014

3. P1241: Assessing the long-term impact of disesae-modifying therapies: Preliminary results from the comparing Australia and New Zealand MS populations (COMPANZ) study;Claflin,2018

4. The neurobiology of multiple sclerosis;Compston,2005

5. International physical activity questionnaire: 12-country reliability and validity;Craig;Med. Sci. Sports Exercise,2003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fatigue in multiple sclerosis: A UK MS-register based study;Multiple Sclerosis and Related Disorders;2022-08

2. The effect of national disease-modifying therapy subsidy policy on long-term disability outcomes in people with multiple sclerosis;Multiple Sclerosis Journal;2021-08-13